Virtus LifeSci Biotech Products ETF
15 hedge funds and large institutions have $10.1M invested in Virtus LifeSci Biotech Products ETF in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.67% more ownership
Funds ownership: 33.22% → 35.9% (+2.7%)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$863K | |
| 2 | +$548K | |
| 3 | +$141K | |
| 4 |
CAMG
CWA Asset Management Group
Naples,
Florida
|
+$51.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$32K |
Top Sellers
| 1 | -$764K | |
| 2 | -$56.4K | |
| 3 | -$55.3K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$33K |